Interestingly, after administration of the cytotoxic SST conjugate, AN-238 (doxorubicin-SST conjugate synthesized by coupling pyrrolino-doxorubicin to the SST analog RC-121), on day 13, the anti-tumor bystander effect observed in mixed tumors was significantly extended to day 20. The gene discussed is SST; the disease is neoplasm.